Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Sanofi Pasteur's new H5N1 vaccine shows promise

Sanofi pasteur, the vaccines division of sanofi-aventis Group, has announced data showing that its new investigational H5N1 pandemic influenza vaccine containing a proprietary adjuvant achieved a high immune response at the lowest dose of H5N1 antigen reported to date.

18 Sep 2007

China culls 33,000 ducks to contain bird flu outbreak

Authorities in China say a suspected outbreak of the H5N1 bird flu virus has been discovered among ducks in an outlying district of the southern city of Guangzhou.

17 Sep 2007

Key differences discovered between avian and human flu

St. Jude scientists have found key features that distinguish influenza viruses found in birds from those that infect humans.

5 Sep 2007

Indonesia denies human to human spread of bird flu

The Indonesian government has been forced to speak out about the continued spread of bird flu in the vast archipelago following the release of an analysis which suggests the deadly virus had been spread by person to person contact.

4 Sep 2007

One species' entire genome discovered inside another's

Scientists at the University of Rochester and the J. Craig Venter Institute have discovered a copy of the entire genome of a bacterial parasite residing inside the genome of its host species.

30 Aug 2007

$75 million extra for pandemic flu preparedness

HHS Secretary Mike Leavitt has announced that the Department is making available another $75 million to states, territories and four metropolitan areas to help strengthen their capacity to respond to a pandemic influenza outbreak.

30 Aug 2007

Limited human-to-human spread of Avian-flu virus in Indonesia in 2006 confirmed

In the first systematic, statistical analysis of its kind, infectious-disease-modeling experts at Fred Hutchinson Cancer Research Center confirm that the avian influenza A (H5N1) virus in 2006 spread between a small number of people within a family in Indonesia.

28 Aug 2007

MedImmune licenses reverse genetics technology to Novartis

MedImmune, Inc. has announced that it has licensed its proprietary reverse genetics intellectual property to Novartis to support the development and construction of new vaccine strains to produce inactivated human seasonal, pre-pandemic and pandemic influenza vaccines.

24 Aug 2007

Roche and WHO reinforce Tamiflu as primary H5N1 treatment

The World Health Organization (WHO) has reinforced that Tamiflu (oseltamivir) is the primary recommended antiviral of choice in managing patients infected with H5N1 in updated guidance published on the WHO website today.

24 Aug 2007

Global public health security in the 21st century

More than at any previous time in history, global public health security depends on international cooperation and the willingness of all countries to act effectively in tackling new and emerging threats.

23 Aug 2007

WHO says more killer diseases like AIDS on their way

The World Health Organisation (WHO) has warned the world to expect a new killer disease to emerge in the next few years which will threaten the lives of millions.

23 Aug 2007

Bali hit by bird flu again

There has been another death from bird flu in Bali; this time the victim is a 28-year-old woman.

22 Aug 2007

Flu vaccines more effective when sweetened

Scientists in Australia have discovered a simple way of making flu vaccines much more effective.

21 Aug 2007

New target for the development of anti-influenza drugs

Scientists at Cure Lab, Inc., a biotechnology company based in Canton, Massachusetts, in collaboration with researchers at Boston University and Harvard Medical School have discovered a potential new target for the development of anti-influenza (flu) drugs, including those that may be effective against potentially pandemic influenza strains like H5N1.

17 Aug 2007

Most flu shot plans do not address how to vaccinate hard-to-reach populations

Most flu immunization plans in the United States do not address how to vaccinate hard-to-reach populations (HTR)--undocumented immigrants, substance users, the homeless, homebound elderly, and minorities--and this potentially dangerous omission can lead masses of people to become ill during an outbreak of pandemic flu or other contagious disease, according to a new study by the New York Academy of Medicine in the current issue of the Journal of Urban Health.

17 Aug 2007

Preventing the spread of zoonotic diseases

Instead of attacking wild birds for our new disease problems, a far more cost effective approach should focus on keeping wild animals separate in the places where they often commingle: in wildlife markets and international trade, according to wildlife health experts from the Wildlife Conservation Society (WCS) and the United Nations Food and Agriculture Organization (FAO) in a recent issue of the prestigious Journal of Wildlife Diseases.

17 Aug 2007

Baxter awarded major contract for flu vaccine in the event of a pandemic

Baxter International Inc. has announced that Baxter's European subsidiary in the United Kingdom has entered into an advanced supply agreement with the Department of Health that contains an option to purchase pandemic influenza vaccine in the event the World Health Organization (WHO) declares a pandemic.

From Baxter International Inc. 17 Aug 2007

Bird flu death in Bali - Australians on alert

Health officials in Indonesia have confirmed the first human death from bird flu in Bali in a village in the north-west district of Jembrana, an area where poultry is known to be affected.

13 Aug 2007

Scientists prepare for future pandemic strains of H5N1

Preparing vaccines and therapeutics that target a future mutant strain of H5N1 influenza virus sounds like science fiction, but it may be possible, according to a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and a collaborator at Emory University School of Medicine.

11 Aug 2007